Investors who defy the crowd with these trades might profit handsomely.
Managed-care stocks are priced as if Obamacare spells their demise.
Strong demand for antiflu medicine, Tamiflu, pushes up sales 10%.
Walgreen up on better-than-expected results; data chaos for Sequenom.
Auto retailer revs up; drugstore retailer pulls back.
Upgrade gives Bubble Wrap maker a pop; drug trial disappoints investors.
Biotech firm's drug delights investors; Palm's new phone disappoints.
If denosumab gets approval from the FDA, it will pump new life into Amgen.
America's Car-Mart beats the Street; Acadia plunges after drug fails trial.
CVS Caremark will benefit from the flood of branded drugs going generic.